Mizuho raised the firm’s price target on Plains GP Holdings (PAGP) to $22 from $20 and keeps an Outperform rating on the shares. The firm expects a positive market reaction to Plains’ sale of its Canadian natural gas liquids business to Keyera. The deal lends credence to the view Plains could use proceeds to buy in the Plains-Oryx Permian joint venture, and/or position itself as a cleaner pure-play crude story that is better positioned to participate in potential industry consolidation, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAGP:
- Plains GP Holdings Sells Canadian NGL Business
- Plains All American, Plains GP to sell NGL business to Keyera for $3.75B
- Plains GP Holdings Holds Successful Annual Shareholder Meeting
- Plains GP Holdings price target lowered to $20 from $21 at Mizuho
- Plains GP Holdings price target lowered to $18 from $21 at Citi